Alpha-internexin expression predicts outcome in anaplastic oligodendroglial tumors and may positively impact the efficacy of chemotherapy: European organization for research and treatment of cancer trial 26951.
about
Adjuvant treatment of anaplastic oligodendrogliomas and oligoastrocytomasMitotic index, microvascular proliferation, and necrosis define 3 groups of 1p/19q codeleted anaplastic oligodendrogliomas associated with different genomic alterations.Contribution of 1p, 19q, 9p and 10q Automated Analysis by FISH to the Diagnosis and Prognosis of Oligodendroglial Tumors According to WHO 2016 Guidelines.IDH mutations in human gliomaEfficacy and patient-reported outcomes with dose-intense temozolomide in patients with newly diagnosed pure and mixed anaplastic oligodendroglioma: a phase II multicenter study.The clinical implications and biologic relevance of neurofilament expression in gastroenteropancreatic neuroendocrine neoplasms.Combining two biomarkers, IDH1/2 mutations and 1p/19q codeletion, to stratify anaplastic oligodendroglioma in three groups: a single-center experience.Expression pattern of neuronal intermediate filament α-internexin in anterior pituitary gland and related tumors.Alpha-internexin and altered CIC expression as a supportive diagnostic marker for oligodendroglial tumors with the 1p/19q co-deletion.Treatment of large low-grade oligodendroglial tumors with upfront procarbazine, lomustine, and vincristine chemotherapy with long follow-up: a retrospective cohort study with growth kinetics.Immunohistochemical detection of IDH1 mutation, p53, and internexin as prognostic factors of glial tumors.Molecular analysis of diffuse intrinsic brainstem gliomas in adults.Impact of 9p deletion and p16, Cyclin D1, and Myc hyperexpression on the outcome of anaplastic oligodendrogliomas.Construction of a specific SVM classifier and identification of molecular markers for lung adenocarcinoma based on lncRNA-miRNA-mRNA network.Loss of expression and prognosis value of alpha-internexin in gastroenteropancreatic neuroendocrine neoplasm.
P2860
Q24194645-66200163-B64D-4708-AC5A-1B59BF0832D4Q34062043-17186E53-5229-4443-9B29-E36867C5E603Q36234884-67B8647F-F57D-424F-8C6D-21D5BAC61ECEQ38022856-76F92161-880E-45D6-A6B7-CDF2EEBA8D88Q38298229-1024CFE1-C4E0-4AAC-9FE1-CC8154D1C0DEQ39459743-1D775A0D-6F3D-44A7-AA82-C4279E646821Q44754640-A816A8EE-7DF0-4169-9FFF-BA86EB8A0A11Q45986885-6362EF83-7FAB-4CDA-801A-6E0CC72381D2Q46044500-35870962-4D24-4A9A-B156-AF805B502B14Q48475366-7E8D2B7E-60CA-4459-8993-3D174DE28598Q48626253-14E08E21-122B-4527-A360-92F2EECDEED3Q48867807-540F5ADA-2598-4406-8F72-026A2885789FQ54123926-D18EE759-1268-4495-B3C5-E2C5F2276AA7Q55175083-B86A87A9-52E5-47D4-B4FA-7B3E1D1C55BFQ55512934-B307C143-37BB-4D1C-BD95-A018DEB58AFA
P2860
Alpha-internexin expression predicts outcome in anaplastic oligodendroglial tumors and may positively impact the efficacy of chemotherapy: European organization for research and treatment of cancer trial 26951.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Alpha-internexin expression pr ...... eatment of cancer trial 26951.
@en
Alpha-internexin expression pr ...... eatment of cancer trial 26951.
@nl
type
label
Alpha-internexin expression pr ...... eatment of cancer trial 26951.
@en
Alpha-internexin expression pr ...... eatment of cancer trial 26951.
@nl
prefLabel
Alpha-internexin expression pr ...... eatment of cancer trial 26951.
@en
Alpha-internexin expression pr ...... eatment of cancer trial 26951.
@nl
P2093
P2860
P50
P356
P1433
P1476
Alpha-internexin expression pr ...... eatment of cancer trial 26951.
@en
P2093
Johan M Kros
Karima Mokhtari
Khe Hoang-Xuan
Marc Sanson
Martin Taphoorn
Martin Van den Bent
Thierry Gorlia
P2860
P304
P356
10.1002/CNCR.25827
P407
P577
2011-01-18T00:00:00Z